HIVandHepatitis.com
HIV and AIDS Topics
Top News Articles
 
FDA-approved Treatments 
Experimental Treatments
Women / Children
Metabolic Complications
Opportunistic Infections
 Google Custom Search

Women and Children
Pregnancy / Breast-feeding / MTCT

Mortality and Causes of Death among Women with HIV in the U.S.: A 10-Year Study
6-16-2009

Defensin Genes and Viral Factors May Influence Likelihood of Mother-to-child HIV Transmission
5/22/09


Lopinavir/ritonavir (Kaletra) Is Superior to Nevirapine (Viramune) for HIV-infected Children Who Received Single-dose Nevirapine at Birth
5/15/09

Metabolic and Body Shape Abnormalities Are Common in Children and Youth with HIV
5/15/09

Long-term Study Finds No Link between Maternal Use of Antiretroviral Therapy -- including Efavirenz (Sustiva) -- and Birth Defects
4/28/09

Raltegravir (Isentress) Reaches High Levels in the Genital Tract of HIV Negative Women, Suggesting Potential for Preventive Therapy
4/24/09

Studies Examine Bone Loss in Women with HIV
4/17/09

Treatment Response, Mortality, and Adverse Events in Children with HIV
1/13/09

HIV Can Enter Healthy Genital Tissue of Women
1/09/09

Darunavir (Prezista) and Abacavir (Ziagen) Approved for Children with HIV
1/06/09

Treatment Interruption May Be Appropriate for Selected Adults and Children with HIV if CD4 Count is Maintained at a High Level
11/18/2008

Perceptions of Care by HIV-Infected Women in the United States
11/05/2008

Darunavir (Prezista) Receives Full Traditional Approval, Dose Set for Treatment-naive Patients, Caution Urged for Pregnant Women
10/24/08

Cancer and Long-term Toxicities in Children Exposed to Antiretroviral Drugs before Birth
10/21/08

Didanosine (Videx EC) Product Label Updated with New Dosing Recommendations for HIV Positive Children
10/03/08

Zidovudine (Retrovir) Product Label Updated with New Dosing Recommendations for Children with HIV
9/25/08

Antiretroviral Therapy during Pregnancy Significantly Reduces Mother-to-child HIV Transmission, but is Linked to Low Birth Weight
9/23/08

Exposure to Antiretroviral Drugs during Pregnancy Does Not Impair HIV Negative Children's Mental Development
8/22/08

Women and Men Respond Similarly to Antiretroviral Drugs and Experience Comparable Side Effects: GRACE, M05-730, CASTLE, ARTEM

8/19/2008


Social Stigma Felt by Pregnant HIV Positive Women in the U.S.
8/19/2008

U.S. Government Updates HIV Treatment Guidelines for Children
8/19/2008

ACOG Recommends Routine HIV Testing for All Women Ages 19-64, Regardless of Individual Risk Factors
8/08/08

Extended-dose Nevirapine (Viramune) for Infants to Prevent HIV Transmission via Breastfeeding in Ethiopia, India, and Uganda
8/01/08


Successful Early Treatment of HIV Positive Infants with 3-class HAART in Resource-limited Settings
8/01/08

Is the Increased Incidence of Asthma in HIV Positive Children Treated with HAART Due to Immune Reconstitution?
8/01/08

Crack Cocaine Use Predicts HIV Disease Progression and Mortality in HIV Positive Women
7/29/08

HIV Persists in Breast Milk despite Antiretroviral Therapy
7/22/08

Efavirenz (Sustiva) in Breast Milk and Blood Plasma of Mothers and Newborns
7/22/08

Studies Show High Rates of Cancer-causing Human Papillomavirus Infection among HIV Positive Women in Africa
7/15/08

HIV Positive Children and Adolescents Have Elevated Risk of Cardiovascular Disease
7/08/08


Updated Guidelines for Prevention and Treatment of Opportunistic Infections in HIV Positive Adults, Adolescents, and Children
7/08/08


New Tipranavir (Aptivus) Oral Solution Approved for Treatment-experienced Children and Adolescents with HIV
7/04/08


Adding Tenofovir (Viread) plus Emtricitabine (Emtriva) to Short-course Zidovudine (Retrovir) and Single-dose Nevirapine (Viramune) Does Not Reduce the Risk of Mother-to-child HIV Transmission
6/20/08


Extended Antiretroviral Prophylaxis Lowers Risk of Mother-to-child HIV Transmission during Breast-feeding, but Early Weaning Is Detrimental
6/17/08

Double-boosted Protease Inhibitors Saquinavir (Invirase) and Lopinavir/ritonavir (Kaletra) Produce Significant CD4 Rise and Viral Load Decline in Treatment-experienced Children
6/10/08

Oral Therapy Reduces Incidence of Bacterial Vaginosis and Promotes Vaginal Health in HIV Positive Women
6/03/08

FDA Proposes New Rule to Provide Updated Information on Use of Prescription Drugs and Biological Products during Pregnancy and Breast-feeding
5/30/08


FDA and Pfizer Set Specifications Allowing Nelfinavir (Viracept) to Again Be Prescribed for Children and Pregnant Women
5/23/08


Body Fat and Blood Lipid Levels in Men and Women with HIV
5/16/08

Antiretroviral Therapy and Other Interventions Can Nearly Eliminate Risk of Mother-to-Child HIV Transmission
5/13/08

"Women Living Positive: It's My Life" National Summit Webcast
4/11/08

Lower-Strength Lopinavir/Ritonavir (Kaletra, Aluvia) Tablet Approved in Europe for Children with HIV
4/11/08

Protease Inhibitors Linked to Elevated Cholesterol in HIV-infected Children
4/04/08

 

 

 

 

 

 

 

 

 

 

 

 

 









































 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Protease Inhibitors
Agenerase (amprenavir)
Aptivus
(tipranavir)
Crixivan
(indinavir)
Invirase
(saquinavir hard gel)
Kaletra
(lopinavir/ritonavir)
Lexiva
(fosamprenavir)
Norvir
(ritonavir)
Prezista
(darunavir)
Reyataz
(atazanavir)
Viracept
(nelfinavir)
Nucleoside / Nucleotide Reverse
Transcriptase Inhibitors
Combivir (zidovudine/lamivudine)
Epivir (lamivudine; 3TC)
Emtriva (emtricitabine; FTC)
Epzicom (abacavir + lamivudine)
Retrovir (zidovudine; AZT)
Trizivir (abacavir + zidovudine +lamivudine)
Truvada  (tenofovir / emtricitabine)
Videx (didanosine; ddI)
Viread (tenofovir)
Zerit (stavudine; d4T)
Ziagen (abacavir)
non Nucleoside Reverse
Transcriptase Inhibitors
Etravirine (Intelence; TMC125)
Rescriptor (delavirdine)
Sustiva (efavirenz)
Viramune (nevirapine)
Entry Inhibitors
(including Fusion Inhibitors)
Fuzeon (enfuvirtide, T-20)
Selzentry
(maraviroc)
Fixed Dose Combinations
Atripla (efavirenz + emtricitabine + tenofovir)
Combivir (zidovudine + lamivudine)
Trizivir (abacavir + zidovudine + lamivudine)
Truvada (tenofovir + emtricitabine)
Integrase Inhibitor
Isentress (raltegravir)